2Kameyama K, Okinaga H, Takami H. Clinical manifestations of familial medullary thyroid carcinoma. Biomed Pharmacother, 2004, 58:348-350.
3Yip L, Lee J E, Shapiro S E, et al, Surgical management of hereditary pheochromocytoma. J Am Coil Surg, 2004, 198: 525-534.
4Walther M M, Keiser H R, Choyke P L, et al. Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol, 1999, 161:395- 398.
5Salomon L, Rabii R, Soulie M, et al. Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma. J Urol, 2001, 165:1871-1874.
6Wahher M M, Herring J, Choyke P L, et al. Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol, 2000, 164:14-17.
7Ilias I, Yu J, Carrasquillo J A, et al. Superiority of 6-[18F]- fluorodopamine positron emission tomography versus [131I]- metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab, 2003, 88:4083-4087.
8Pacak K, Eisenhofer G, Carrasquillo J A, et al. 6-[18F] fluorodopamine positron emission tomographic(PET) scanning for diagnostic localization of pheochromocytoma. Hypertension, 2001, 38:6-8.
9Lenders J W, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet, 2005, 366..665-675.
10Hernandez F C, Sdnchez M, Alvarez A, et al. A five-year re port on experience in the detection of pheochromocytoma. Clin Biochem, 2000, 33:649-655.
